ILMN Stock Analysis: Buy, Sell, or Hold?
ILMN - Illumina Inc
$142.54
-0.70 (-0.49%)
▼
5d:
+0.47%
30d:
+7.4%
90d:
+22.03%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Smart Money Accumulation
ILMN is down 7.8% this week, but smart money is accumulating calls. Top strike: $150 2026-06-18 with 936 OI. Call ratio: 68% View Scanner →
Strength: 5.6/10
Get Alerted When ILMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ILMN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ILMN is fairly valued with market pricing in 0.2% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: ILMN is fairly valued with market pricing in 0.2% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$213.84
Based on 8.6% avg growth
INTRINSIC VALUE TODAY
$132.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ILMN is currently trading at $142.54, which is considered extended relative to its 30-day fair value range of $125.73 to $140.34. The stock's valuation (Forward PE: 24.1) is in line with its historical norms (24.0). At these levels, the market is pricing in 0.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ILMN is in a strong uptrend. Immediate support is located at $133.97, while resistance sits at $150.20.
Market Sentiment: ILMN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ILMN is in a strong uptrend. Immediate support is located at $133.97, while resistance sits at $150.20.
Market Sentiment: ILMN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$125.73 -
$140.34
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding ILMN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($140.67)
- NEUTRAL: Market pricing in 0.2% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$125.73 -
$140.34
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$133.97
Resistance Level
$150.20
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.11
Wall Street Target
$140.67
(-1.3%)
Revenue Growth (YoY)
4.8%
Earnings Growth (YoY)
6.1%
Profit Margin
19.4%
Valuation Premium vs History
+0.2% premium
PE vs Historical
24.1 vs 24.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$142.83
(+0%)
2-Year Target
$143.11
(+0%)
3-Year Target
$143.40
(+1%)
3-Yr Target (if PE normalizes)
(PE: 24→24)
PE COMPRESSION
$142.73
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.1, Growth: 13.2%)
$206.76
(+45%)
Base:
(SPY PE: 22.1, Growth: 13.2%)
$189.25
(+33%)
Bear:
(PE: 18.8, Growth: 13.2%)
$160.86
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (26x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 26.04 | Current EPS (TTM): $5.50
Bull Case
$169.35
(+19%)
Analyst growth 7.5%, PE expands to 28.7
Base Case
$153.96
(+8%)
Market implied 7.5%, PE stable at 26.0
Bear Case
$97.40
(-32%)
Severe decline -20.0%, PE contracts to 22.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ILMN showing a specific setup today?
Insider Activity (6 Months)
2
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Patricia Leckman
SELL
2370 shares
2026-02-18
Gilbert Ray Cisneros, Jr.
BUY
2026-02-10
Scott Gottlieb
BUY
200 shares
2026-02-09
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
Advanced ILMN Option Strategies
Professional options setups generated by AI based on today's ILMN price and gamma walls.
